These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11384642)

  • 1. Is there evidence for preferential delivery of ovarian estradiol to the endometrium?
    Tourgeman DE; Boostanfar R; Chang L; Lu J; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2001 Jun; 75(6):1156-8. PubMed ID: 11384642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and clinical effects of micronized estradiol administered vaginally or orally.
    Tourgeman DE; Slater CC; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2001 Jan; 75(1):200-2. PubMed ID: 11163838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical localization of endometrial insulin-like growth factor binding protein-1 and -3 during the luteal phase in controlled ovarian hyperstimulation cycles: a controlled study.
    Brown SE; Mandelin E; Oehninger S; Toner JP; Seppala M; Jones HW
    Fertil Steril; 2000 Aug; 74(2):338-42. PubMed ID: 10927055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal versus oral E(2) administration: effects on endometrial thickness, uterine perfusion, and contractility.
    Fanchin R; Righini C; Schönauer LM; Olivennes F; Cunha Filho JS; Frydman R
    Fertil Steril; 2001 Nov; 76(5):994-8. PubMed ID: 11704123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program.
    Shapiro H; Cowell C; Casper RF
    Fertil Steril; 1993 May; 59(5):1055-8. PubMed ID: 8486173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue hormone levels of vaginally and orally administered estradiol.
    Tourgeman DE; Gentzchein E; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1480-3. PubMed ID: 10368494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
    Escudero EL; Boerrigter PJ; Bennink HJ; Epifanio R; Horcajadas JA; Olivennes F; Pellicer A; Simón C
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2081-8. PubMed ID: 15483085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a novel vaginal progesterone preparation in a donor oocyte program.
    Gibbons WE; Toner JP; Hamacher P; Kolm P
    Fertil Steril; 1998 Jan; 69(1):96-101. PubMed ID: 9457941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transdermal versus oral estradiol on endometrial receptivity.
    Krasnow JS; Lessey BA; Naus G; Hall LL; Guzick DS; Berga SL
    Fertil Steril; 1996 Feb; 65(2):332-6. PubMed ID: 8566257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles.
    Levi AJ; Drews MR; Bergh PA; Miller BT; Scott RT
    Fertil Steril; 2001 Oct; 76(4):670-4. PubMed ID: 11591397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.
    Hofmann GE; Bentzien F; Bergh PA; Garrisi GJ; Williams MC; Guzman I; Navot D
    Fertil Steril; 1993 Oct; 60(4):675-9. PubMed ID: 8405524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone.
    Taylor HS; Daftary GS; Selam B
    Fertil Steril; 2003 Sep; 80 Suppl 2():839-43. PubMed ID: 14505762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors.
    Develioglu OH; Hsiu JG; Nikas G; Toner JP; Oehninger S; Jones HW
    Fertil Steril; 1999 Jun; 71(6):1040-7. PubMed ID: 10360907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exogenous gonadotropins on endometrial maturation in oocyte donors.
    Meyer WR; Novotny DB; Fritz MA; Beyler SA; Wolf LJ; Lessey BA
    Fertil Steril; 1999 Jan; 71(1):109-14. PubMed ID: 9935126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis.
    Paulson RJ; Sauer MV; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):321-5. PubMed ID: 9022610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone administration in patients with absent ovaries.
    Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure.
    Bourgain C; Devroey P; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Hum Reprod; 1990 Jul; 5(5):537-43. PubMed ID: 2394784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.